NCT05040438View on ClinicalTrials.gov

Natural Killer (NK) Cell Therapy in Locally Advanced HCC

PHASE2CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

October 15, 2019

Primary Completion Date

September 14, 2023

Study Completion Date

September 14, 2023

Conditions
Locally Advanced Hepatocellular Carcinoma
Interventions
BIOLOGICAL

Vax-NK/HCC

autologous NK cells expanded ex vivo.

Trial Locations (1)

58141

Seon-Ah Ha, Hwasun

All Listed Sponsors
lead

Vaxcell Bio, Co., Ltd.

INDUSTRY

NCT05040438 - Natural Killer (NK) Cell Therapy in Locally Advanced HCC | Biotech Hunter | Biotech Hunter